相关实验视频
里瓦罗克萨班与埃诺沙巴林用于全膝关节整形术后的血栓预防 (RECORD4):一项随机试验
Alexander G G Turpie1, Michael R Lassen, Bruce L Davidson
1McMaster University, Hamilton, Ontario L8L 2X2, Canada. turpiea@mcmaster.ca
Lancet (London, England)
|May 5, 2009
概括
口服里瓦洛克萨班在全膝关节整形术后预防静脉血栓塞栓症方面表现出优异的疗效,与埃诺沙巴林相比. 这项研究支持对接受膝关节置换手术的患者进行有效的口服预防,以缩短住院时间.
科学领域:
- 整形外科手术 整形外科手术
- 药理学 药理学是指药理学的学科.
- 血管医学 血管医学
背景情况:
- 静脉血栓塞栓症 (VTE) 预防在全膝关节整形术 (TKA) 后是标准的.
- 口服抗凝剂可能有助于缩短住院时间.
- 研究了口服里瓦罗克萨班在TKA VTE预防中的有效性和安全性.
研究的目的:
- 为了评估口服里瓦罗克萨班与埃诺沙巴林在TKA后的VTE预防方面的疗效.
- 评估与里瓦洛克萨班相关的安全概况,特别是重大出血事件.
主要方法:
- 一个随机的,双盲的III期试验,涉及3148名接受TKA的患者.
- 患者接受口服里瓦罗克萨班 (每天10毫克) 或皮下埃诺沙巴林 (每天两次30毫克) 治疗.
- 强制性静脉扫描是在11-15天之间进行的;主要有效性是复合VTE或死亡,主要安全性是严重出血.
主要成果:
- 里瓦罗克萨班在统计学上显著地减少了静脉瘤发作事件 (6.9%与10.1%,p=0.0118).
- 在0.7%的里瓦洛克萨班患者和0.3%的埃诺沙巴林患者中发生严重出血 (p=0.1096).
- 发现里瓦罗克萨班的疗效不低于,而且在疗效上优于埃诺沙巴林.
结论:
- 口服里瓦洛克萨班 (10毫克每天一次,持续10-14天) 是TKA后静脉突发动脉瘤预防的优越选择.
- 这些发现支持使用口服抗凝药来改善患者的康复和潜在的更短的住院治疗.
相关概念视频
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...